INNT
TOTAL INVALIDATION PROCESSED BY THE IB
19/04/2025
Voltar para busca
Dado oficial do USPTO
SEQUESSOME TECHNOLOGY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SEQUESSOME TECHNOLOGY
ST13
US500000079115050Classe
5, 10
Pedido
79115050
Registro
4427020
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
14/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
20/12/2011
Data de registro
05/11/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/05/2024
Última transação
14/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Berkshire, GB
Examinador
TWOHIG,SHANNON MARIE
Unidade examinadora
L50
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Pro Bono Bio Entrepreneur Limited
Pro Bono Bio Entrepreneur Limited
Representantes
Roberta S. Bren MUNCY, GEISSLER, OLDS & LOWE, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substances for the treatment of pain and inflammation; veterinary and sanitary preparations and substances for the treatment of pain and inflammation; chemical preparations for pharmaceutical purposesfor the treatment of pain and inflammation; pharmaceuticals for the treatment of osteoarthritisoncologycardiovascular diseaserespiratory diseaseinflammationinfectiongastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; anti-inflammatory drugs; medicated creamsmedicated dispersionsmedicated lotionsmedicated ointmentsmedicated gelsmedicated solutionsmedicated spraysmedicated lacquers and pharmaceutical solutions which form a film on the skin for the treatment of pain or inflammation; chemical preparations for pharmaceutical or medical purposesthe treatment of pain and inflammation; pharmaceuticals in the fields of osteoarthritisoncologycardiovascular diseaserespiratory diseaseinflammationinfectiongastrointestinal disease and central nervous system diseasesvesicles which physically absorb and remove chemicals; pharmaceutical preparationstopical and parenteral preparations in the form of vesicles; pharmaceutical preparations in the form of vesicles for medical and veterinary purposes; pharmaceutical preparations being chemical membranes and chemical aggregates for medical and veterinary purposes for the treatment of pain and inflammation; pharmaceutical preparations of arachidonic acids for the treatment of pain and inflammation; dispersions for pharmaceuticals for the treatment of pain and inflammation; medicated cosmetic and veterinary preparationsdispersions and dry preparations of liposomal active substance carriers for the treatment of pain and inflammation; cosmeceutical preparations in the nature of medicated cosmetics; pharmaceutical preparationslipids for topical and parenteral use for the treatment of pain and inflammation; surfactants for medical use dispersed in the form of liquidscreamsgelslotionsliquid treatment sprays and lotionsbeing pharmaceutical preparations for the treatment of or prevention of cancerinfectious diseasesfungal diseasesdisease caused by parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasesinherited diseasesingle gene disordersdiseases of mouthteethskinhair and earbone and blood diseases and reproductive system disordersthe treatment of inflammationasthmaatopic eczemadishydrotic hand eczemaplaque-type psoriasisseborrhoeic eczemaacne vulgarisbronchospasmatherothrombotic cardiovascular disordersvenous thrombotic disorderspaindysmenorrheahypercholesterolemiahypertriglyceridemiafatty acid metabolismmetal or other toxicityAlzheimer's diseasegoutmacular degenerationfungal disease and disorders related to fatty acid deficiencies
Classe 10
Medical devices in the nature of a carrier with nanostructures which cross through the skin allowing subcutaneous absorption for the treatment of pain; molecular filtering devices for medical usea liquidgel or cream preparation as a drug delivery device which filters through or migrates into the skin and has a physical therapeutic effect; medical and veterinary devicesa medical device in which vesicles act as a drug delivery device in the nature of non-pharmaceutical nanostructures that migrate through the skin and which contribute to the lubricating properties of synovial fluid ; medical instruments and devices for the administration of skin disease therapy and pain therapy and prophylaxis preparations and substances
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/04/2025
INPC
INVALIDATION PROCESSED
01/04/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
18/01/2025
C71T
CANCELLED SECTION 71
17/05/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/11/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/01/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
07/01/2020
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
07/01/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
05/11/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/08/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/11/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/03/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/03/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/02/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/02/2014
FIMP
FINAL DISPOSITION PROCESSED
07/02/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/02/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/08/2013
PUBO
PUBLISHED FOR OPPOSITION
20/08/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/07/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
17/07/2013
ALIE
ASSIGNED TO LIE
17/07/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/07/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/07/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/07/2013
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/07/2013
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/03/2013
GNFR
FINAL REFUSAL E-MAILED
08/03/2013
CNFR
FINAL REFUSAL WRITTEN
08/03/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/02/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/02/2013
ALIE
ASSIGNED TO LIE
12/02/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2013
RFNT
REFUSAL PROCESSED BY IB
01/09/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/08/2012
RFRR
REFUSAL PROCESSED BY MPU
10/08/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/08/2012
CNRT
NON-FINAL ACTION WRITTEN
09/08/2012
MAFR
APPLICATION FILING RECEIPT MAILED
07/08/2012
DOCK
ASSIGNED TO EXAMINER
03/08/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/08/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEQUESSOME TECHNOLOGY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.